Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement
Jason M. Uslaner, Christopher J. Winrow, Anthony L. Gotter, et al.
Behavioural Brain Research (2014) Vol. 269, pp. 61-65
Closed Access | Times Cited: 35

Showing 26-50 of 35 citing articles:

The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor
David A. Perrey, Ann M. Decker, Jun‐Xu Li, et al.
Bioorganic & Medicinal Chemistry (2015) Vol. 23, Iss. 17, pp. 5709-5724
Open Access | Times Cited: 17
Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system
Jennifer E. Fragale, Morgan H. James, Gary Aston‐Jones
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 15
The dual orexin receptor antagonist TCS1102 does not affect reinstatement of nicotine-seeking
Shaun Yon‐Seng Khoo, Gavan P. McNally, Kelly J. Clemens
PLoS ONE (2017) Vol. 12, Iss. 3, pp. e0173967-e0173967
Open Access | Times Cited: 15
Involvement of orexin-2 receptor in the ventral tegmental area in stress- and drug priming-induced reinstatement of conditioned place preference in rats
Ronak Azizbeigi, Abbas Haghparast
Neuroscience Letters (2018) Vol. 696, pp. 121-126
Closed Access | Times Cited: 13
More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder
Megan J. Moerke, Lance Richard McMahon, Jenny L. Wilkerson
Pharmacological Reviews (2020) Vol. 72, Iss. 2, pp. 527-557
Open Access | Times Cited: 10
Drug addiction co-morbidity with alcohol: Neurobiological insights
M. Adrienne McGinn, Caroline B. Pantazis, Brendan J. Tunstall, et al.
International review of neurobiology (2021), pp. 409-472
Closed Access | Times Cited: 5
Dual Orexin Receptor Antagonists (DORAs) as an Adjunct Treatment for Smoking Cessation
Ajna Hamidovic
CNS Drugs (2022) Vol. 36, Iss. 5, pp. 411-417
Closed Access | Times Cited: 3
Orexin Receptor Antagonists
Daniël Hoyer, Laura H. Jacobson
Current Sleep Medicine Reports (2017) Vol. 3, Iss. 4, pp. 342-353
Open Access | Times Cited: 1
The Orexin System and Nicotine Addiction: Preclinical Insights
Shaun Yon‐Seng Khoo, Gavan P. McNally, Kelly J. Clemens
Elsevier eBooks (2019), pp. 509-517
Open Access | Times Cited: 1
Overview of withdrawal syndrome mechanisms in different substance abuse addictions: Neuronal circuits and transmitters
Famitafreshi Hamidreza, Karimian Morteza
Journal of Addiction Medicine and Therapeutic Science (2020), pp. 070-076
Open Access
Previous Page - Page 2

Scroll to top